GlobalData: GLP-1R agonists poised to redefine chronic disease treatment beyond diabetes and obesity
From metabolic disorders, to neurodegenerative, the chronic aspect of these conditions makes them the most prevalent in our society, and it seems that some mechanisms of action are common to most of them.